Home Tags TLR8 agonist

Tag: TLR8 agonist

Silverback Raises U.S. $78.5 Million to Advance SBT6050 into the Clinic...

Seattle-based Silverback Therapeutics™, a biopharmaceutical company pioneering a new class of immune-modulating ImmunoTAC™ drug conjugates targeting previously inaccessible disease pathways, confirmed that it has...

X